Cargando…

Residential treatment and medication treatment for opioid use disorder: The role of state Medicaid innovations in advancing the field

BACKGROUND: Mortality due to opioid use continues to increase; effective strategies to improve access to treatment for opioid use disorder (OUD) are needed. While OUD medications exist, they are used infrequently and often not available in residential addiction treatment settings. CMS provides expan...

Descripción completa

Detalles Bibliográficos
Autores principales:	O'Brien, Peggy L., Stewart, Maureen T., Shields, Morgan C., White, Mackenzie, Dubenitz, Joel, Dey, Judith, Mulvaney-Day, Norah
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Full Length Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9495301/ https://www.ncbi.nlm.nih.gov/pubmed/36157615 http://dx.doi.org/10.1016/j.dadr.2022.100087

Ejemplares similares

Medicaid expansion and opioid supply policies to address the opioid overdose crisis
por: Shakya, Shishir, et al.
Publicado: (2022)

Treatment setting among individuals with opioid use and criminal legal involvement, housing instability, or Medicaid insurance, 2015-2021
por: Shearer, Riley D., et al.
Publicado: (2023)

Sustainment of contingency management within opioid treatment programs: COVID-related barriers and innovative workflow adaptations
por: Becker, Sara J., et al.
Publicado: (2021)

Opioid-Related Treatment Disparities Among Medicaid Enrollees in Indiana
por: Vivas-Valencia, Carolina, et al.
Publicado: (2023)

From parenting skills to adolescent treatment needs: Questions elicited by parents of adolescents discharged from residential treatment
por: Kelly, Lourah M., et al.
Publicado: (2022)

Inter-class Concomitant Pharmacotherapy in Medicaid-Insured Youth Receiving Psychiatric Residential Treatment
por: Edelsohn, Gail A., et al.
Publicado: (2021)

Medicaid-financed residential care for persons with mental retardation
por: Lakin, K. Charlie, et al.
Publicado: (1990)

Implementing tobacco-free policy in residential substance use disorders treatment: Practice changes among staff
por: Campbell, Barbara K., et al.
Publicado: (2022)

Hospitalist perspectives on buprenorphine treatment for inpatients with opioid use disorder
por: Reed, Megan K, et al.
Publicado: (2022)

Virtual opioid agonist treatment: Alberta’s virtual opioid dependency program and outcomes
por: Day, Nathaniel, et al.
Publicado: (2022)

Differences in medicaid expansion effects on buprenorphine treatment utilization by county rurality and income: A pharmacy data claims analysis from 2009–2018
por: Golan, Olivia K., et al.
Publicado: (2023)

Telemedicine Buprenorphine Initiation and Retention in Opioid Use Disorder Treatment for Medicaid Enrollees
por: Hammerslag, Lindsey R., et al.
Publicado: (2023)

Removal of Medicaid Prior Authorization Requirements and Buprenorphine Treatment for Opioid Use Disorder
por: Christine, Paul J., et al.
Publicado: (2023)

Medicaid expansion and treatment for opioid use disorders in Oregon: an interrupted time-series analysis
por: McCarty, Dennis, et al.
Publicado: (2019)

The impact of opioid prescribing report cards in Medicaid
por: Candon, Molly, et al.
Publicado: (2022)

Opioid treatment program prescribing of methadone with community pharmacy dispensing: Pilot study of feasibility and acceptability
por: Brooner, Robert K., et al.
Publicado: (2022)

Critical access medication for opioid use disorder (MOUD) treatment facilities in the continental United States
por: Pollack, Harold A., et al.
Publicado: (2022)

Psychiatric comorbidities and their treatment predict buprenorphine continuation among postpartum people with opioid use disorder
por: Shadowen, Hannah, et al.
Publicado: (2022)

Medicaid expansion in Oregon and postpartum healthcare among people with and without prenatal substance use disorder()
por: Haight, Sarah C., et al.
Publicado: (2022)

Disparities in opioid treatment access and retention among women based on pregnancy status from 2006 to 2017
por: Khachikian, Tenie, et al.
Publicado: (2022)

Specific polysubstance use patterns predict relapse among patients entering opioid use disorder treatment
por: Pan, Yue, et al.
Publicado: (2022)

The relationship between reincarceration and treatment of opioid use disorder with extended-release naltrexone among persons with HIV
por: Parchinski, Kaley, et al.
Publicado: (2023)

State- and County-Level Geographic Variation in Opioid Use Disorder, Medication Treatment, and Opioid-Related Overdose Among Medicaid Enrollees
por: Lindner, Stephan R., et al.
Publicado: (2023)

DataView: Profile of Persons With Disabilities in Medicare and Medicaid
por: Davis, Margaret H., et al.
Publicado: (1996)

The Center for Medicare and Medicaid Innovation: The Case for Reform
por: Badger, Doug
Publicado: (2022)

Opioid agonist treatment initiation and linkage for hospitalized patients seen by a substance use disorder consultation service
por: Nordeck, Courtney D., et al.
Publicado: (2022)

Listening to women and pregnant and postpartum people: Qualitative research to inform opioid use disorder treatment for pregnant and postpartum people
por: Guille, Constance, et al.
Publicado: (2022)

Association of Buprenorphine-Waivered Physician Supply With Buprenorphine Treatment Use and Prescription Opioid Use in Medicaid Enrollees
por: Wen, Hefei, et al.
Publicado: (2018)

Trends in Engagement With Opioid Use Disorder Treatment Among Medicaid Beneficiaries During the COVID-19 Pandemic
por: Tilhou, Alyssa Shell, et al.
Publicado: (2022)

Legislating Medicaid: Considering Medicaid and Its Origins
por: Moore, Judith D., et al.
Publicado: (2005)

Prescription stimulant use during long-term opioid therapy and risk for opioid use disorder
por: Scherrer, Jeffrey F., et al.
Publicado: (2022)

Association of Medicaid Expansion With Opioid Overdose Mortality in the United States
por: Kravitz-Wirtz, Nicole, et al.
Publicado: (2020)

New chronic opioid use in Medicaid patients following cholecystectomy
por: Lockett, Mark A, et al.
Publicado: (2022)

Implementation of an Opioid Management Initiative by a State Medicaid Program
por: Garcia, Maria M., et al.
Publicado: (2014)

Open‐label long‐term treatment of add‐on triheptanoin in adults with drug‐resistant epilepsy
por: Borges, Karin, et al.
Publicado: (2020)

Impact of COVID-19 on household waste flows, diversion and reuse: The case of multi-residential buildings in Toronto, Canada
por: Ikiz, Ece, et al.
Publicado: (2021)

Changes in Medicaid Fee-for-Service Benefit Design for Substance Use Disorder Treatment During the Opioid Crisis, 2014 to 2021
por: Shoulders, Angela, et al.
Publicado: (2023)

Prescription Opioid Quality Measures Applied Among Pennsylvania Medicaid Enrollees
por: Cochran, Gerald, et al.
Publicado: (2018)

Medicaid Expansion and Prescription Trends: Opioids, Addiction Therapies, and Other Drugs
por: Cher, Benjamin A.Y., et al.
Publicado: (2019)

Association of chronic non-cancer pain status and buprenorphine treatment retention among individuals with opioid use disorder: Results from electronic health record data
por: John, William S., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5bcggo3h1cddpaskt88ipr16hk